3161 - 3170 of 8620 Results
Title
Year
- Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, α -Synuclein Synthesis, Interleukin-1β Release, and Cholinergic Action.2013OPENTitle: Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, α -Synuclein Synthesis, Interleukin-1β Release, and Cholinergic Action.Journal Name: Anti-Inflammatory & Anti-Allergy Agents in Medicinal ChemistryPublisher: Bentham Science Publishers Ltd.Vol: 12Issue #: 2Start Page: 117End Page: 128Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/1871523011312020003Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5214460Citation Count: 26
- Gastric dysregulation induced by microinjection of 6-OHDA in the substantia nigra pars compacta of rats is determined by alterations in the brain-gut axis2014OPENTitle: Gastric dysregulation induced by microinjection of 6-OHDA in the substantia nigra pars compacta of rats is determined by alterations in the brain-gut axisJournal Name: American Journal of Physiology-Gastrointestinal and Liver PhysiologyPublisher: American Physiological SocietyVol: 307Issue #: 10Start Page: G1013End Page: G1023Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/ajpgi.00258.2014Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4865236Citation Count: 47
- Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer’s Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial2016OPENTitle: Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer’s Disease With Aggression or Agitation: The CitAD Randomized Clinical TrialJournal Name: American Journal of PsychiatryPublisher: American Psychiatric Association PublishingVol: 173Issue #: 5Start Page: 465End Page: 472Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1176/appi.ajp.2015.15050648Best OA location URL: https://ajp.psychiatryonline.org/doi/pdf/10.1176/appi.ajp.2015.15050648Citation Count: 86
- Vagally mediated effects of brain stem dopamine on gastric tone and phasic contractions of the rat2017OPENTitle: Vagally mediated effects of brain stem dopamine on gastric tone and phasic contractions of the ratJournal Name: American Journal of Physiology-Gastrointestinal and Liver PhysiologyPublisher: American Physiological SocietyVol: 313Issue #: 5Start Page: G434End Page: G441Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/ajpgi.00180.2017Best OA location URL: https://www.physiology.org/doi/pdf/10.1152/ajpgi.00180.2017Citation Count: 23
-
OPENTitle: Plasma neuronal exosomal levels of Alzheimer's disease biomarkers in normal agingJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 3Issue #: 5Start Page: 399End Page: 403Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.309Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.309Citation Count: 67
- Presence of Striatal Amyloid Plaques in Parkinson's Disease Dementia Predicts Concomitant Alzheimer's Disease: Usefulness for Amyloid Imaging2012OPENTitle: Presence of Striatal Amyloid Plaques in Parkinson's Disease Dementia Predicts Concomitant Alzheimer's Disease: Usefulness for Amyloid ImagingJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 2Issue #: 1Start Page: 57End Page: 65Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-2012-11073Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3423968Citation Count: 40
-
OPENTitle: Declining Quality of Life in Parkinson Disease Before and After DiagnosisJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 2Issue #: 2Start Page: 153End Page: 160Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-2012-12083Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3744127Citation Count: 12
- Peripheral Administration of the Selective Inhibitor of Soluble Tumor Necrosis Factor (TNF) XPro®1595 Attenuates Nigral Cell Loss and Glial Activation in 6-OHDA Hemiparkinsonian Rats2014OPENTitle: Peripheral Administration of the Selective Inhibitor of Soluble Tumor Necrosis Factor (TNF) XPro®1595 Attenuates Nigral Cell Loss and Glial Activation in 6-OHDA Hemiparkinsonian RatsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 4Issue #: 3Start Page: 349End Page: 360Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-140410Best OA location URL: http://doi.org/10.3233/JPD-140410Citation Count: 103
-
OPENTitle: Peripheral Biomarkers of Parkinson’s Disease Progression and Pioglitazone EffectsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 5Issue #: 4Start Page: 731End Page: 736Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-150666Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5061495Citation Count: 29
- Prevalence of Submandibular Gland Synucleinopathy in Parkinson’s Disease, Dementia with Lewy Bodies and other Lewy Body Disorders2016OPENTitle: Prevalence of Submandibular Gland Synucleinopathy in Parkinson’s Disease, Dementia with Lewy Bodies and other Lewy Body DisordersJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 6Issue #: 1Start Page: 153End Page: 163Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-150680Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5498170Citation Count: 67